Concord Biotech Limited Cash Flow Reinvestment Rate
Concord Biotech Limited cash flow reinvestment rate. Concord Biotech Limited (CONCORDBIO) has a Cash Flow Reinvestment Rate of 0.45x as of March 2025, reinvesting Rs1.11 Billion (capex Rs1.11 Billion ) from operating cash flow of Rs2.47 Billion. Explore Concord Biotech Limited (CONCORDBIO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Concord Biotech Limited (2020–2025)
Cash flow reinvestment rate of Concord Biotech Limited from 2020 to 2025. Historical reinvestment intensity for Concord Biotech Limited across 6 annual periods. Explore Concord Biotech Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Concord Biotech Limited Cash Flow Reinvestment Rate by Year (2020–2025)
Concord Biotech Limited cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for Concord Biotech Limited. For the full cash flow conversion analysis, see cash flow conversion of Concord Biotech Limited.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | Rs1.11 Billion | Rs2.47 Billion | Rs1.11 Billion | ▲ +39.2% |
| 2024 | 0.32x | Rs856.88 Million | Rs2.65 Billion | Rs856.88 Million | ▼ -45.3% |
| 2023 | 0.59x | Rs1.45 Billion | Rs2.46 Billion | Rs1.45 Billion | ▼ -21.3% |
| 2022 | 0.75x | Rs1.56 Billion | Rs2.07 Billion | Rs1.56 Billion | ▼ -38.8% |
| 2021 | 1.22x | Rs2.04 Billion | Rs1.67 Billion | Rs2.04 Billion | ▲ +21.9% |
| 2020 | 1.00x | Rs1.55 Billion | Rs1.55 Billion | Rs1.55 Billion | — |